HomeCompareNPKYY vs CL

NPKYY vs CL: Dividend Comparison 2026

NPKYY yields 3.96% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NPKYY wins by $402.2K in total portfolio value
10 years
NPKYY
NPKYY
● Live price
3.96%
Share price
$11.38
Annual div
$0.45
5Y div CAGR
50.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$443.1K
Annual income
$243,801.89
Full NPKYY calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — NPKYY vs CL

📍 NPKYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPKYYCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPKYY + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPKYY pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPKYY
Annual income on $10K today (after 15% tax)
$336.26/yr
After 10yr DRIP, annual income (after tax)
$207,231.61/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, NPKYY beats the other by $202,597.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPKYY + CL for your $10,000?

NPKYY: 50%CL: 50%
100% CL50/50100% NPKYY
Portfolio after 10yr
$242.1K
Annual income
$124,626.79/yr
Blended yield
51.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

NPKYY
No analyst data
Altman Z
3.2
Piotroski
4/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPKYY buys
0
CL buys
0
No recent congressional trades found for NPKYY or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPKYYCL
Forward yield3.96%2.44%
Annual dividend / share$0.45$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR50.8%28.6%
Portfolio after 10y$443.1K$41.0K
Annual income after 10y$243,801.89$5,451.69
Total dividends collected$400.8K$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NPKYY vs CL ($10,000, DRIP)

YearNPKYY PortfolioNPKYY Income/yrCL PortfolioCL Income/yrGap
1← crossover$11,297$596.57$11,014$313.84+$283.00NPKYY
2$13,037$949.79$12,200$415.44+$837.00NPKYY
3$15,495$1,544.82$13,607$553.09+$1.9KNPKYY
4$19,167$2,587.58$15,301$741.41+$3.9KNPKYY
5$25,019$4,511.08$17,374$1,002.00+$7.6KNPKYY
6$35,070$8,299.06$19,958$1,367.44+$15.1KNPKYY
7$53,919$16,394.67$23,243$1,887.87+$30.7KNPKYY
8$93,219$35,524.76$27,512$2,642.43+$65.7KNPKYY
9$186,302$86,557.67$33,197$3,759.22+$153.1KNPKYY
10$443,145$243,801.89$40,973$5,451.69+$402.2KNPKYY

NPKYY vs CL: Complete Analysis 2026

NPKYYStock

Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electromechanical systems, and cleaning agents and chemicals. This segment also provides color materials, including inkjet colorants, dyes for textiles and papers, and materials for thermal paper; catalysts for the production of acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company also engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.

Full NPKYY Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this NPKYY vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPKYY vs SCHDNPKYY vs JEPINPKYY vs ONPKYY vs KONPKYY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.